Nicole Fram M.D.
Quick facts
Marketed products
- Prolensa 0.07% Ophthalmic Solution · Ophthalmology
Prolensa is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce inflammation and pain in the eye.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: